Pharmaceutical Research Management srl   Report issue

For profit Phase 2 Phase 3
Founded: Lodi Italy (2011)

Organization Overview

First Clinical Trial
2016
NCT02722603
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Pharmaceutical Research Management srl

Active Ingredients

Drugs in Phase 3 Trials (2)

gabapentin (neurontin) (2 trials)

tramadol (Ultram) (1 trial)

Drugs in Phase 2 Trials (1)

morphine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3